These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21597485)

  • 1. One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration.
    Arora S; McKibbin M
    Eye (Lond); 2011 Aug; 25(8):1034-8. PubMed ID: 21597485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration.
    Panos GD; Gatzioufas Z; Petropoulos IK; Dardabounis D; Thumann G; Hafezi F
    Drug Des Devel Ther; 2013; 7():565-9. PubMed ID: 23874084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
    Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
    Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable response of vascularized pigment epithelial detachments to ranibizumab based on lesion subtypes, including polypoidal choroidal vasculopathy.
    Inoue M; Arakawa A; Yamane S; Kadonosono K
    Retina; 2013 May; 33(5):990-7. PubMed ID: 23446653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration.
    Shima C; Gomi F; Sawa M; Sakaguchi H; Tsujikawa M; Tano Y
    Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):899-906. PubMed ID: 19308441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
    Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments.
    Lommatzsch A; Heimes B; Gutfleisch M; Spital G; Zeimer M; Pauleikhoff D
    Eye (Lond); 2009 Dec; 23(12):2163-8. PubMed ID: 19197318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study.
    Sarraf D; London NJ; Khurana RN; Dugel PU; Gune S; Hill L; Tuomi L
    Ophthalmology; 2016 Oct; 123(10):2213-24. PubMed ID: 27566855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomical and visual outcomes of ranibizumab injections in retinal pigment epithelium tears.
    Erol MK; Ozdemir O; Coban DT; Ceran BB; Sari ES
    Arq Bras Oftalmol; 2015; 78(3):168-72. PubMed ID: 26222106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal ranibizumab for the treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration.
    Iordanous Y; Powell AM; Mao A; Hooper PL; Eng KT; Schwartz C; Kertes PJ; Sheidow TG
    Can J Ophthalmol; 2014 Aug; 49(4):367-76. PubMed ID: 25103655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration.
    Chan CK; Abraham P; Sarraf D; Nuthi AS; Lin SG; McCannel CA
    Eye (Lond); 2015 Jan; 29(1):80-7. PubMed ID: 25277305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
    Introini U; Torres Gimeno A; Scotti F; Setaccioli M; Giatsidis S; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
    el Matri L; Chebil A; Kort F; Bouraoui R; Baklouti K; Mghaieth F
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):779-84. PubMed ID: 20169357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].
    Lommatzsch A; Heimes B; Gutfleisch M; Spital G; Dietzel M; Pauleikhoff D
    Ophthalmologe; 2011 Mar; 108(3):244-51. PubMed ID: 20571805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab.
    Wolf A; Rüping J; Neubauer AS; Mayer W; Ulbig M; Haritoglou C; Holz FG; Eter N; Kampik A
    Retina; 2013 Oct; 33(9):1843-9. PubMed ID: 23598795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal anti-VEGF therapy for vascularized pigment epithelium detachment in age-related macular degeneration.
    Giansanti F; Bacherini D; Giacomelli G; Virgili G; Finocchio L; Fiore T; Vannozzi L; Menchini U
    Eur J Ophthalmol; 2014; 24(3):402-8. PubMed ID: 24242217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment.
    Zhao C; Zhang Z; Chen L; Wang F; Xu D
    Med Sci Monit; 2016 Mar; 22():833-9. PubMed ID: 26972376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept.
    Tyagi P; Juma Z; Hor YK; Scott NW; Ionean A; Santiago C
    BMC Ophthalmol; 2018 Jun; 18(1):148. PubMed ID: 29929478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.